NCT00390000View on ClinicalTrials.gov

Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

January 25, 2007

Primary Completion Date

August 4, 2016

Study Completion Date

August 4, 2016

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

vatalanib

Given orally

DRUG

pemetrexed disodium

Given IV

OTHER

pharmacological study

Correlative study

PROCEDURE

ultrasound imaging

Correlative study

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER